GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

UCLA SPORE in Brain Cancer

$2,139,000
Linda M Liau · University Of California Los Angeles · P50 · FY2019 · CA

DF/HCC Kidney Cancer SPORE

$2,139,000
David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2019 · CA

UCLA SPORE in Brain Cancer

$2,139,000
Linda M Liau · University Of California Los Angeles · P50 · FY2021 · CA

SPORE for Translational Approaches to Brain Cancer

$2,138,999
Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2022 · CA

SPORE in Myeloid Malignancies

$2,138,999
Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2019 · CA

SPORE in Myeloid Malignancies

$2,138,999
Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2021 · CA

SPORE in Bladder Cancer

$2,138,849
Dean F. Bajorin · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA

SPORE in Bladder Cancer

$2,138,849
Dean F. Bajorin · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA

SPORE in Bladder Cancer

$2,138,532
Dean F. Bajorin · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA

Head and Neck Cancer SPORE at the University of Wisconsin

$2,133,489
Paul M Harari · University Of Wisconsin-Madison · P50 · FY2025 · CA

Mayo Clinic Breast Cancer SPORE

$2,130,960
James Newell Ingle · Mayo Clinic Rochester · P50 · FY2007 · CA

Mayo Clinic Breast Cancer SPORE

$2,130,960
James Newell Ingle · Mayo Clinic Rochester · P50 · FY2009 · CA

Mayo Clinic Breast Cancer SPORE

$2,130,960
James Newell Ingle · Mayo Clinic Rochester · P50 · FY2008 · CA

The University of Texas MD Anderson Cancer Center SPORE in Melanoma

$2,127,987
Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA

Molecular Analysis Of Human Natural Killer Cells

$2,127,153
Eric O Long · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system

$2,125,666
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Strategies for Cancer Immunotherapy Development: Preclinical Studies

$2,125,238
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Brain Tumor Clinical and Clinical Research Program

$2,120,708
Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2024 · CA

Targeting Lung Cancer Vulnerabilities

$2,120,114
John D Minna · Ut Southwestern Medical Center · P50 · FY2022 · CA

Preclinical drug development in pancreatic cancer

$2,113,368
Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Targeting Lung Cancer Vulnerabilities

$2,110,656
John D Minna · Ut Southwestern Medical Center · P50 · FY2023 · CA

Mechanisms of Nucleic Acid Enzymes - Pol Beta and Mammalian Base Repair Enzymes

$2,106,781
Samuel H Wilson · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES

LICI Microbiome and Genetics Core

$2,106,010
Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA

SPORE in Brain Cancer

$2,094,780
Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA

Centers for Cancer Systems Therapeutics (CaST)

$2,090,840
Andrea Califano · Columbia University Health Sciences · U54 · FY2018 · CA